Recombinant activated factor VII in the management of massive obstetric bleeding

Blood Coagul Fibrinolysis. 2006 Apr;17(3):226-7. doi: 10.1097/01.mbc.0000220249.42907.ff.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Abruptio Placentae
  • Cesarean Section / adverse effects
  • Drug Costs
  • Factor VII / metabolism
  • Factor VIIa / economics
  • Factor VIIa / therapeutic use*
  • Fatal Outcome
  • Female
  • Fetal Death
  • Hemorrhage / prevention & control
  • Humans
  • Postoperative Hemorrhage / drug therapy*
  • Postoperative Hemorrhage / etiology
  • Pregnancy
  • Recombinant Proteins / therapeutic use
  • Spain

Substances

  • Recombinant Proteins
  • Factor VII
  • Factor VIIa